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Plasma viremia can be effectively suppressed and main-
tained below the limits of detection for extended periods of
time in most human immunodeficiency virus (HIV)–
infected individuals receiving antiretroviral therapy (ART).
However, it has not been possible to eradicate HIV by ART
alone, likely due in part to the persistence of various viral
reservoirs in lymphoid tissues. In this regard, the existence
of latently infected, resting CD4
+ T cells carrying replica-
tion-competent HIV has posed one of the major challenges
to the long-term control or eradication of HIV in infected
individuals on ART. Consequently, there has been consid-
erable focus on therapeutic strategies to reactivate the
latent viral reservoir using various agents, such as cytokines,
histone deacetylase inhibitors, and mitogens, under the
assumption that these cells would die due to HIV induced
cytopathic effects and antiretroviral drugs would prevent
spread of infection. However, such approaches have shown
no clinical benefit to date. Moreover, it also has become
clear that HIV persists in subsets of CD4
+ T cells in blood
and lymphoid tissues of infected individuals receiving ART.
Recent data from our laboratory will be discussed which
will include potential mechanisms of HIV persistence and
prospects for eradication and new therapeutic approaches
in HIV-infected individuals receiving effective ART.
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